Cookie Einstellungen
Diese Webseite verwendet ausschließlich notwendige Cookies, die für die Funktion erforderlich sind. Marketing- und Statistik-Cookies kommen nicht zum Einsatz. Weitere Informationen finden Sie in unserer Datenschutzerklärung.
 Notwendig   Details einblenden
      OK      
Bitte logge Dich ein, um diese Funktion zu nutzen!
      OK      
x
Impact News +++ Organogenesis forecasts 2026 revenue of $179M-$215M amid June restructuring expected to cut $18M annually (SeekingAlpha) +++ ORGANOGENESIS Aktie -18,51%

RESMED Aktie

 >RESMED Aktienkurs 
177.95 EUR    -8.2%    (TradegateBSX)
Ask: 178 EUR / 57 Stück
Bid: 175.05 EUR / 58 Stück
Tagesumsatz: 13 Stück
Realtime Kurs von 7:30 bis 22 Uhr!
RESMED Aktie über LYNX handeln
>RESMED Performance
1 Woche: +6,5%
1 Monat: -0,7%
3 Monate: +7,9%
6 Monate: -15,5%
1 Jahr: -19,6%
laufendes Jahr: -7,4%
>RESMED Aktie
Name:  RESMED INC. DL-,004
Land:  USA
Sektor:  Gesundheit
ISIN/ Wkn:  US7611521078 / 895878
Symbol/ Ticker:  RME (Frankfurt) / RMD (NYSE)
Kürzel:  FRA:RME, ETR:RME, RME:GR, NYSE:RMD
Index:  S&P500
Webseite:  https://investor.resmed.c..
Profil:  ResMed Inc. is a healthcare company that develops and supplies digital health technologies and cloud-connected medical devices for respiratory care. Its core products support the treatment of sleep apnea, COPD, and other chronic diseases through flow..
>Volltext..
Marktkapitalisierung:  27069.88 Mio. EUR
Unternehmenswert:  26359.1 Mio. EUR
Umsatz:  4802.46 Mio. EUR
EBITDA:  1897.68 Mio. EUR
Nettogewinn:  1317.79 Mio. EUR
Gewinn je Aktie:  9.03 EUR
Schulden:  731.21 Mio. EUR
Liquide Mittel:  1440.02 Mio. EUR
Operativer Cashflow:  1639.01 Mio. EUR
Bargeldquote:  1.23
Umsatzwachstum:  3.26%
Gewinnwachstum:  8.35%
Dividende je Aktie:  2.05 EUR
Dividendenrendite:  1.12%
Dividendenschätzung:  1.12%
Div. Historie:  14.05.26 - 0.51204€
12.02.26 - 0.50544006€
>weitere anzeigen...
Insiderhandel:  2 Insider verkauften innerhalb der letzten 30 Tage Aktien im Wert von 2.509.219 Euro.
Suchwörter:  RESMED
Letzte Datenerhebung:  07.08.26
>RESMED Kennzahlen
Aktien/ Unternehmen:
Aktien: 145.06 Mio. St.
Frei handelbar: 99.07%
Leerverk. Aktien: 9.34%
Rückkaufquote: 1.68%
Mitarbeiter: 10600
Umsatz/Mitarb.: 0.42 Mio. EUR
Analysten:
Analystenrating: Buy
Kursziel: 20.42%
Bewertung:
KGV: 21.14
KGV lG: 19.48
KUV: 5.47
KBV: 4.9
PEG-Ratio: 1.22
EV/EBITDA: 13.89
Rentabilität:
Bruttomarge: 60.74%
Gewinnmarge: 27.44%
Operative Marge: 34.76%
Managementeffizenz:
Gesamtkaprendite: 18.59%
Eigenkaprendite: 25.25%
>RESMED Peer Group
Gesundheit, Lungen- & Atemwegserkrankungen/ -behandlung, Medizinprodukte & -technik/ Implantate/ Wundpflege
 
07.08.26 - 07:36
 ResMed raises dividend by 10% to $0.66 (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
07.08.26 - 06:12
 Why ResMed shares are tumbling 6% today despite strong results (Fool)
 
Here's what spooked investors. The post Why ResMed shares are tumbling 6% today despite strong results appeared first on The Motley Fool Australia....
07.08.26 - 04:48
 Why James Hardie, Avita Medical and ResMed shares are turning heads on Friday (Fool)
 
Why is everyone talking about Avita Medical, ResMed, and James Hardie shares today? The post Why James Hardie, Avita Medical and ResMed shares are turning heads on Friday appeared first on The Motley Fool Australia....
07.08.26 - 04:30
 Resmed turns in record fourth quarter revenue of US$1.5B (Market Herald)
 
AI-powered digital health solutions specialist Resmed Inc. (ASX:RMD) has unveiled impressive results…...
07.08.26 - 03:57
 ResMed expects FY 2027 revenue of $5.75B-$5.85B and non-GAAP EPS of $12-$12.25 while accelerating $1.85B+ shareholder returns (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
07.08.26 - 01:12
 ResMed posts strong Q4 earnings, lifts dividend (Fool)
 
The sleep disorder treatment company had another record quarter. The post ResMed posts strong Q4 earnings, lifts dividend appeared first on The Motley Fool Australia....
07.08.26 - 01:01
 Insiderhandel: Aufsichtsrat verkauft Aktien von ResMed im Wert von 1800000 USD (Insiderkauf)
 
Farrell, Peter C. - Aufsichtsrat - Tag der Transaktion: 2026-08-05...
07.08.26 - 01:00
 ResMed (RMD) Q4 Earnings and Revenues Top Estimates (Zacks)
 
ResMed (RMD) delivered earnings and revenue surprises of +1.72% and +0.17%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?...
07.08.26 - 00:54
 ResMed: Gewinn übertrifft Erwartungen, doch Aktie bricht nachbörslich nach Umsatzverfehlung ein (Investing.com DE)
 
Um den gesamten Artikel unter de.investing.com zu lesen, klicken Sie bitte auf die Überschrift...
06.08.26 - 23:00
 Resmed Inc Announces Increase In Q4 Income (AFX)
 
WASHINGTON (dpa-AFX) - Resmed Inc (RMD.AX) reported a profit for its fourth quarter that Increases, from the same period last yearThe company's earnings came in at $383.432 million, or $2.64 per s......
06.08.26 - 11:24
 Buy, hold, sell: Orora, Virgin Australia, and ResMed shares (Fool)
 
Ord Minnett has given its verdict on these shares. The post Buy, hold, sell: Orora, Virgin Australia, and ResMed shares appeared first on The Motley Fool Australia....
05.08.26 - 18:15
 What to Expect From These 2 MedTech Stocks This Earnings Season? (Zacks)
 
Globus Medical and Resmed enter the earnings season with growth drivers intact despite tariff, inflation and hospital spending pressures....
28.07.26 - 06:36
 Down 31%: Is there any chance of a rebound from ResMed shares? (Fool)
 
The ASX healthcare shares lost 31% over the past 12 months. The post Down 31%: Is there any chance of a rebound from ResMed shares? appeared first on The Motley Fool Australia....
26.07.26 - 22:24
 ResMed shares are at their cheapest valuation in a decade. Time to pounce? (Fool)
 
A decade-low multiple on a growing business. The post ResMed shares are at their cheapest valuation in a decade. Time to pounce? appeared first on The Motley Fool Australia....
24.07.26 - 04:24
 Buy, hold, sell: Nick Scali, Lendlease, Resmed shares (Fool)
 
Ord Minnett has just released new notes on these three ASX 200 shares. The post Buy, hold, sell: Nick Scali, Lendlease, Resmed shares appeared first on The Motley Fool Australia....
24.07.26 - 01:24
 Why I′d buy Woolworths, ResMed, and CBA shares (Fool)
 
I think these familiar ASX businesses still have more growth and improvement ahead of them. The post Why I'd buy Woolworths, ResMed, and CBA shares appeared first on The Motley Fool Australia....
21.07.26 - 22:42
 BetterInvesting™ Magazine Update on Broadridge Financial Resources Inc. (NYSE:BR) and ResMed Inc. (NYSE:RMD) (PR Newswire)
 
TROY, Mich., July 21, 2026 /PRNewswire/ -- The Editorial Advisory and Securities Review Committee of BetterInvesting Magazine today announced Broadridge Financial Resources Inc.(NYSE: BR) as its "Stock to Study" and ResMed Inc. (NYSE: RMD) as its "Undervalued Stock" in the October 2026......
21.07.26 - 22:36
 Why I′d buy Qantas, Woolworths, and ResMed shares (Fool)
 
These well-known ASX shares have different strengths, and I think each could reward patient investors. The post Why I'd buy Qantas, Woolworths, and ResMed shares appeared first on The Motley Fool Australia....
16.07.26 - 19:06
 ResMed downgraded at RBC Capital Markets on FY27 challenges (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
16.07.26 - 04:12
 How much could ResMed shares rise according to Morgans? (Fool)
 
Current share price weakness could be an opportunity. The post How much could ResMed shares rise according to Morgans? appeared first on The Motley Fool Australia....
>Behalte deine Investments mit realtime Kursen & News im Blick. Finde neue spannende Aktien! Registriere Dich und werde Mitglied!
Zitat des Tages: Ubi lex, ibi poena - Wo ein Gesetz, da auch eine Strafandrohung. - Nomen Nescio
>Aktienauflistung | >Aktienscreener | >Aktienkennzahlen | >Anleihen | >ETFs | >Fonds | >Branchen | >Länder | >Themen | >Redaktionen
Partner:    >TradegateBSX Börse | >Dukascopy | >TradingView | >Boersentreff- Partner

Börsentreff auf Facebook | Börsentreff auf X | Börsentreff auf Instagram

Copyright @ Boersentreff.de - Die Märkte im Blick!